Journal of Clinical Pediatrics >
A case of clinical report of T-lymphoblastic lymphoma secondary to acute promyelocytic leukemia in children
Received date: 2023-12-20
Online published: 2024-08-06
Objective To summarize the clinical process of patients with non-Hodgkin 's lymphoma (NHL) secondary to acute leukemia after treatment, and to explore the mechanism of NHL secondary to acute leukemia after treatment. Methods The clinical data of child with T-lymphoblastic lymphoma (T-LBL) secondary to acute promyelocytic leukemia (APL) was retrospectively analyzed, and the literature reports of NHL secondary to acute leukemia after treatment were summarized. Results The patient was a 10-year-old boy who presented with "intermittent fever" and was diagnosed with APL. After treatment, bone marrow relapsed and a complete remission was achieved after adjusting the treatment regimen, however, T-LBL was diagnosed due to enlarged lymph nodes at the end of the leukemia treatment, and remission was achieved again after standardized chemotherapy. Searching the literature over the last 10 years, a total of 9 cases of non-Hodgkin's lymphoma secondary to acute leukemia treatment have been reported, all in adults, and 6 of these patients were disease-free survival up to the time of reporting. Conclusion The incidence of secondary NHL after acute leukemia treatment is low and the prognosis is favorable. In addition, for patients after chemotherapy for neoplastic diseases, it is crucial to monitor the incidence of secondary tumors and employ advanced diagnostic techniques to enhance understanding of the pathophysiology underlying these secondary malignancies.
Key words： acute promyelocytic leukemia; T-lymphoblastic lymphoma; child
Ye WANG , Linlin ZHANG , Zuofei CHI , Ruowen SUN , Zehui JIANG , Gang XU . A case of clinical report of T-lymphoblastic lymphoma secondary to acute promyelocytic leukemia in children[J]. Journal of Clinical Pediatrics, 2024 , 42(8) : 722 -727 . DOI: 10.12372/jcp.2024.23e1211
| [1] | Yilmaz M, Kantarjian H, Ravandi F. Acute promyelocytic leukemia current treatment algorithms[J]. Blood Cancer J, 2021, 11(6): 123. |
| [2] | Burkhardt B, Hermiston ML. Lymphoblastic lymphoma in children and adolescents: review of current challenges and future opportunities[J]. Br J Haematol, 2019, 185(6): 1158-1170. |
| [3] | Rosolen A, Perkins SL, Pinkerton CR, et al. Revised international pediatric non-Hodgkin lymphoma staging system[J]. J Clin Oncol, 2015, 33(18): 2112-2118. |
| [4] | 中国肿瘤临床学会指南工作委员会. 中国临床肿瘤学会(CSCO)淋巴瘤诊疗指南2021[M]. 北京: 人民卫生出版社, 2021. |
| [5] | Zanoni L, Bezzi D, Nanni C, et al. PET/CT in non-Hodgkin lymphoma: an update[J]. Semin Nucl Med, 2023, 53(3): 320-351. |
| [6] | 张冉, 李慧慧, 汤爱萍, 等. 急性单核细胞性白血病伴脑淋巴瘤1例[J]. 南昌大学学报(医学版), 2010, 50(8): 122-122. |
| [7] | 翁翔, 黄强, 杨天新, 等. 急性淋巴细胞白血病缓解9年后继发非霍奇金淋巴瘤1例[J]. 肿瘤学杂志, 2015, 21(7): 621-622. |
| [8] | 谢水玲, 林传明, 刘礼平, 等. 急性早幼粒细胞白血病继发弥漫大B细胞淋巴瘤1例[J]. 赣南医学院学报, 2023, 43(4): 395-396. |
| [9] | Iturrate I, Loscertales J, Fernández-Ruiz E, et al. Angioimmunoblastic T-cell lymphoma after acute myeloid leukemia: alleged common pathogenesis. A case report and literature review[J]. Clin Case Rep, 2020, 8(12): 3494-3497. |
| [10] | Ding C, Huang Y, Shi M, et al. CD20-negative primary middle ear diffuse large B-cell lymphoma coexpressing MYC and BCL-2 secondary to acute lymphoblastic leukemia: a case report[J]. Medicine (Baltimore), 2019, 98(15): e15204. |
| [11] | Kawashiri A, Nakagawa SI, Ishiguro C, et al. Donor-derived diffuse large B-cell lymphoma after haploidentical stem cell transplantation for acute myeloid leukemia[J]. J Clin Exp Hematop, 2022, 62(3): 175-180. |
| [12] | Ririe MR, Florell SR, Miles RR, et al. Secondary diffuse large B-cell lymphoma after chemotherapy for acute myeloid leukemia: looking for the unexpected diagnosis[J]. Am J Dermatopathol, 2014, 36(7): e125-e128. |
| [13] | Zhou KI, Lin C, Neff JL, et al. Dasatinib-associated follicular lymphoma in a patient with B-cell acute lymphoblastic leukaemia[J]. BMJ Case Rep, 2023, 16(5): e252739. |
| [14] | Higuchi M, Sasaki S, Kawadoko S, et al. Epstein-Barr virus-positive diffuse large B-cell lymphoma following acute myeloid leukemia: a common clonal origin indicated by chromosomal translocation t(3;4)(p25;q21)[J]. Int J Hematol, 2015, 102(4): 482-487. |
| [15] | Eguiguren JM, Ribeiro RC, Pui CH, et al. Secondary non-Hodgkin's lymphoma after treatment for childhood cancer[J]. Leukemia, 1991, 5(10): 908-911. |
| [16] | Al-Juhaishi T, Khurana A, Shafer D. Therapy-related myeloid neoplasms in lymphoma survivors: reducing risks[J]. Best Pract Res Clin Haematol, 2019, 32(1): 47-53. |
| [17] | Metzgeroth G, Walz C, Score J, et al. Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma[J]. Leukemia, 2007, 21(6): 1183-1188. |
| [18] | Chua CC, Fleming S, Wei AH. Clinicopathological aspects of therapy-related acute myeloid leukemia and myelodysplastic syndrome[J]. Best Pract Res Clin Haematol, 2019, 32(1): 3-12. |
| [19] | Bispo JAB, Pinheiro PS, Kobetz EK. Epidemiology and etiology of leukemia and lymphoma[J]. Cold Spring Harb Perspect Med, 2020, 10(6): a034819. |
| [20] | Voso MT, Falconi G, Fabiani E. What's new in the pathogenesis and treatment of therapy-related myeloid neoplasms[J]. Blood, 2021, 138(9): 749-757. |
| [21] | Barazzuol L, Coppes RP, van Luijk P. Prevention and treatment of radiotherapy-induced side effects[J]. Mol Oncol, 2020, 14(7): 1538-1554. |
| [22] | Liu Y, Wang J, Su R, et al. Postoperative radiotherapy-induced leiomyosarcoma in breast cancer: a case report and literature review[J]. Breast Cancer, 2020, 27(4): 780-784. |
| [23] | Rafieemehr H, Maleki Behzad M, Azandeh S, et al. Chemo/radiotherapy-induced bone marrow niche alterations[J]. Cancer Invest, 2021, 39(2): 180-194. |
| [24] | Ballow M, Sánchez-Ramón S, Walter JE. Secondary immune deficiency and primary immune deficiency crossovers: hematological malignancies and autoimmune diseases[J]. Front Immunol, 2022, 13: 928062. |
| [25] | Zhu S, Wang Y, Tang J, et al. Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment[J]. Front Immunol, 2022, 13: 1074477. |
| [26] | Dymicka-Piekarska V, Koper-Lenkiewicz OM, Zińczuk J, et al. Inflammatory cell-associated tumors. Not only macrophages (TAMs), fibroblasts (TAFs) and neutrophils (TANs) can infiltrate the tumor microenvironment. The unique role of tumor associated platelets (TAPs)[J]. Cancer Immunol Immunother, 2021, 70(6): 1497-1510. |
| [27] | Marcelis L, Tousseyn T, Sagaert X. MALT lymphoma as a model of chronic inflammation-induced gastric tumor development[J]. Curr Top Microbiol Immunol, 2019, 421: 77-106. |
| [28] | Dai Y, Shuai X, Kuang P, et al. Philadelphia chromosome with acute myeloid leukemia and concurrent large B cell lymphoma of different origins: a case report[J]. Oncol Lett, 2017, 13(3): 1189-1193. |
| [29] | Li Z, Zhu YX, Plowright EE, et al. The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells[J]. Blood, 2001, 97(8): 2413-2419. |
| [30] | Maeda T, Yagasaki F, Ishikawa M, et al. Transforming property of TEL-FGFR3 mediated through PI3-K in a T-cell lymphoma that subsequently progressed to AML[J]. Blood, 2005, 105(5): 2115-2123. |
| [31] | Pan Y, Meng M, Zheng N, et al. Targeting of multiple senescence-promoting genes and signaling pathways by triptonide induces complete senescence of acute myeloid leukemia cells[J]. Biochem Pharmacol, 2017, 126: 34-50. |
| [32] | Canela A, Martín-Caballero J, Flores JM, et al. Constitutive expression of tert in thymocytes leads to increased incidence and dissemination of T-cell lymphoma in Lck-Tert mice[J]. Mol Cell Biol, 2004, 24(10): 4275-4293. |
/
| 〈 |
|
〉 |
